Section 3 of our HHS submission proposes a voluntary national census of people who report symptoms they attribute to electromagnetic exposure, designed to describe them carefully before anyone draws conclusions.
In 1997, the FCC said independent evaluation was impracticable, “especially” of “whether certain individuals might be ‘hypersensitive’ or ‘electrosensitive’.” In September 2026, seeking comment on the exposure issues the D.C. Circuit had sent back to it, the agency wrote that it does not “anticipate affording such weight to unverifiable or repetitive testimonial submissions.”
Twenty-nine years later, people who attribute their symptoms to electromagnetic exposure still have no diagnostic pathway in the United States, and HHS offers no guidance on their assessment, care or accommodation. As Section 3 of our submission puts it, “Without systematic data, these people enter the record only as testimony.”
Section 3, A National Census of Electromagnetic Hypersensitivity (EHS, IEI-EMF), and EMF as a Potential Amplifier of Existing Health Conditions, proposes a way to collect those data: a voluntary census built on two questionnaires applied the same way everywhere. It is one of the eleven documents the EFEIA Institute submitted to the U.S. Department of Health and Human Services (HHS) in response to its Request for Information on electromagnetic fields, radiofrequency radiation and wireless exposure. We filed it on 20 October 2026 with two exhibits, a 2022 school case (3A) and a National Census Plan (3B), and it is now part of the public record.
What is known, and what is not
The World Health Organization states that the symptoms “are certainly real” and “can be a disabling problem”, and that “there is no scientific basis to link EHS symptoms to EMF exposure.” Surveys put self-reported EHS at 1.5% in Stockholm County and 3.2% of California adults.
Across 46 blind or double-blind experiments with 1,175 volunteers, a review found no robust evidence that exposure triggers the symptoms, and a role for nocebo, in which the expectation of harm produces symptoms. A WHO-commissioned review of 41 studies with 2,874 participants found people with IEI-EMF no better than others at determining exposure.
Most such studies have design weaknesses, with selection bias in 82% of 28 provocation studies, and the review that found them judges an effect unlikely, though not excluded, for a few individuals. Provocation studies rarely test each person’s own exposure at home, and delayed responses remain an open question. EFEIA recognizes the suffering without asserting a causation that has not been consistently shown.
The cost of having no pathway
In Stockholm County, 12.1% of people reporting EHS were unemployed, against 4.4% of referents. The U.S. Access Board stated in 2002 that electromagnetic sensitivities “may be considered disabilities under the ADA” when they substantially limit a major life activity. CDC told France’s health agency in 2015 that it had no data on EHS.
The section’s second question is whether exposure adds load to conditions people already have, and EFEIA has found no study that tests it with measured exposure. The limits derive from heating: ICNIRP divides 4 W/kg by 50 for the public limit of 0.08 W/kg, and covers people “of differing health statuses” through larger reduction factors. A sleep disorder or a pregnancy is protected against heating only.
Interference with cardiac implants is outside ICNIRP’s scope, and FDA engineers measured fields above the 10 gauss that can trigger the magnet mode of pacemakers and defibrillators at 1 to 11 mm from some smartphone and smartwatch models.
What our data show, and what they cannot
In 2025, 286 people in more than 20 countries enrolled in the EHS Global Census. Questionnaire A records technology habits, including night-time device practices and proximity; B rates 25 symptoms from 0 to 10 each. Among 141 respondents to B, the highest mean severities were fatigue (5.94 of 10), concentration problems (5.15), nervousness (5.13) and insomnia (5.08).
Among the 94 participants who completed all three questionnaires, symptoms correlated more with sleep disruption (r = 0.638) and with sensitivities beyond electromagnetic fields (r = 0.465) than with exposure habits (r = 0.413). Section 3 lists this as an observation, apart from the hypothesis it raises (sleep and wider intolerance are part of the picture) and from the test that hypothesis needs: a cohort with measured bedroom exposure. Participants selected themselves and every answer is self-reported; these are EFEIA’s own cross-sectional data, grade (b). Exhibit 3B asks that the 2025 counts and summary statistics be reconciled before any figure is reused.
In June 2022 (Exhibit 3A), parents’ concerns about students’ symptoms and a nearby cellular base station led to a survey at five public points around a school in Doral, Florida, because access to the school was unavailable. It recorded a mixture of ambient radiofrequency signals, Wi-Fi attributed to the school, and low-frequency electric and magnetic fields near adjacent power lines, which makes an assessment focused only on the base station incomplete.
Fifteen students aged 9 to 16 completed the questionnaire, a selected series with no comparison group (grade b). Parent interviews also described heavy phone and screen use; in the exhibit’s words, the interviews do not justify “replacing an untested base-station explanation with an equally untested cellphone explanation.” The school interior was not evaluated, and the observations do not identify which source, if any, caused the reported symptoms. The symptoms “merit appropriate clinical attention,” and the exhibit calls for a coordinated environmental and clinical follow-up.
A census designed to be tested
Section 3 asks HHS, through its Office of the Assistant Secretary for Health (OASH), to convene and fund a voluntary national program through EFEIA’s National Census Plan, with universities and community partners. NIEHS would support the protocol and analysis, and CDC would advise on case definition and survey methods. Months 1 to 6 would prepare it, months 7 to 18 collect data, and months 19 to 24 produce the analysis and a first national report.
Participants would complete questionnaires A and B only; measurements and clinical review would be separate follow-up, and taking part would never require a purchase. Each form would be scored on its own, with no combined diagnostic total. Recruitment, in English and Spanish, would include people without concerns about exposure. Versions for teenagers and autistic people would require guardian permission and assent, with no adult cutoffs transferred without validation; in Exhibit 3B, autism would be “an accessibility and analysis consideration, not a presumed marker of electromagnetic susceptibility.”
Before any clinical screening use, the questionnaires would have to show reliability, sensitivity and specificity against a reference standard defined in advance. Exhibit 3B adds that psychological processes “can produce genuine physical symptoms and can coexist with medical conditions,” and that the census “would not impose a psychological-versus-physiological classification from A and B alone.” The program would have independent review, disclose EFEIA’s relationship with NOXTAK, and evaluate the screening, not any product.
Our proposal
National Program for the Characterization of Electromagnetic Hypersensitivity
EFEIA proposes to develop a national program for the systematic collection and analysis of information on people who report symptoms attributed to electromagnetic exposure, taking as its starting point its field experience and the assessment instruments it has developed over the years.
The program would apply questionnaires A and B in a standardized way, to collect information on technology-use habits, symptoms and patterns of perceived exposure.
Its aim would be a structured body of information that helps characterize the participating population, identify patterns that require further research and support the design of future scientific and clinical studies.
The program is conceived as a characterization and research initiative, not as a diagnostic test or a procedure that can by itself establish the cause of the symptoms.
What this document does not claim
Section 3 recognizes the suffering of people who report EHS “without asserting a causation that has not been consistently shown.” Each participant’s result would record habits and symptoms “rather than establishing their cause.” Questionnaire scores and score bands are not diagnoses, and clinical use waits for validation. The census correlations come from a self-selected, self-reported, cross-sectional sample, and the school case establishes neither indoor exposure nor a cause. Exhibit 3B states that “national census” implies no compulsory participation, government endorsement or statutory census authority.
Read the document
- Section 3. A National Census of Electromagnetic Hypersensitivity (EHS, IEI-EMF), and EMF as a Potential Amplifier of Existing Health Conditions. https://doi.org/10.5281/zenodo.23523491
- Exhibit 3A. School case study of EHS related symptoms in 15 students: Preliminary assessment using the EFEIA Institute questionnaire and environmental field measurements. Filed with Section 3.
- Exhibit 3B. National Census Plan: Technology Habits and Symptoms Associated with Electromagnetic Sensitivity Concerns. https://doi.org/10.5281/zenodo.23513476
- Filed on 20 October 2026 to docket HHS-OASH-2026-0397 on Regulations.gov. Tracking number: mvh-louw-o1qe.
- All eleven documents, presented together: https://efeia.org/efeia-submission-to-the-hhs/
Disclosure. The EFEIA Institute operates within the NOXTAK Corporation ecosystem. J. Joaquín Machado, EMR Researcher and EFEIA Founder & Director, authored or co-authored the eleven documents and is also NOXTAK’s founder and CTO. This article is published by EFEIA Communications.